Clinical Trial

Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to evaluate the efficacy, cosmetic acceptability and improvement of the stigmatization of the tested product (2039125 03) used bis in die (BID) for 3 months in adult patients suffering from mild to moderate melasma, or mild to moderate acne induced post-inflammatory hyperpigmentation, or solar lentigo.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-02; most recent amendment 2024-08-03.
Status change: Not Yet Recruiting → Recruiting 2024-08-03
Trial Details
NCT Number NCT06253468
Lead Sponsor Cosmetique Active International
Conditions Hyperpigmentation
Enrollment 72 participants
Start Date 2024-06-14
Primary Completion 2025-03 (estimated)
Study Completion 2025-03 (estimated)
Updated on ClinicalTrials.gov 2024-08-06